carbostyril has been researched along with AIDS Seroconversion in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chuang, YC; Hung, CC; Kuo, PH; Liu, WC; Sun, HY; Wu, PY | 1 |
Antinori, A; Castagna, A; Costantini, A; Cozzi-Lepri, A; d'Arminio Monforte, A; Di Biagio, A; Gianotti, N; Lo Caputo, S; Marchetti, G; Mazzarello, G; Mazzotta, V; Rusconi, S | 1 |
Chen, FE; Gu, SX; He, QQ; Liu, J; Wu, HQ; Yang, LM; Zhang, X; Zheng, YT | 1 |
Aghokeng, AF; Chaix, ML; Monleau, M; Nkano, BA; Peeters, M | 1 |
Bousquet, J; Demoly, P; Godard, P; Michel, FB | 1 |
1 review(s) available for carbostyril and AIDS Seroconversion
Article | Year |
---|---|
[Update on drug allergies induced by antibiotics and anti-retroviral agents].
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Drug Hypersensitivity; HIV Seropositivity; Humans; Macrolides; Penicillins; Quinolones | 2000 |
4 other study(ies) available for carbostyril and AIDS Seroconversion
Article | Year |
---|---|
Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cobicistat; Dyslipidemias; Emtricitabine; Female; HIV Seropositivity; Humans; Lipids; Male; Middle Aged; Quinolones; Retrospective Studies; Tenofovir; Weight Gain | 2020 |
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting.
Topics: Adult; CD4 Lymphocyte Count; Cobicistat; Cohort Studies; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV Seropositivity; Humans; Italy; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium; Regression Analysis; Survival Analysis; Treatment Failure | 2019 |
Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity.
Topics: Anti-HIV Agents; Carboxylic Acids; Cell Line, Tumor; Cell Survival; HIV Infections; HIV Seropositivity; HIV-1; Humans; Models, Molecular; Quinolones; Structure-Activity Relationship | 2011 |
Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations.
Topics: Africa South of the Sahara; Algorithms; Amino Acid Sequence; DNA, Viral; Drug Resistance, Viral; Female; HIV Integrase; HIV Integrase Inhibitors; HIV Seropositivity; Humans; Male; Molecular Sequence Data; Mutation; Pyrrolidinones; Quinolones; Raltegravir Potassium | 2012 |